feed,title,long_url,short_url
Benzinga,"Despite Concerns, FDA Advisory Committee Votes In Favor Of Ardelyx's Kidney Disease Candidate",https://benzinga.com/general/biotech/22/11/29761649/despite-concerns-fda-advisory-committee-votes-in-favor-of-ardelyxs-kidney-disease-candidate,https://bit.ly/3gdKH85
Benzinga,NVIDIA To $200? These Analysts Revise Price Targets On The Chip Maker Following Q3 Results,https://benzinga.com/news/earnings/22/11/29764141/nvidia-to-200-these-analysts-revise-price-targets-on-the-chip-maker-following-q3-results,https://bit.ly/3gdKHF7
